Home » Genetron Health Gains CE Mark for COVID-19 Test
Genetron Health Gains CE Mark for COVID-19 Test
April 9, 2020
Beijing-based Genetron Health has received a CE Mark for its novel coronavirus detection kit.
The polymerase chain-reaction test is designed for use with the company’s Genetron S5 sequencer for testing large-scale samples.
The company has also applied to the FDA for emergency use authorization.
Upcoming Events
-
21Oct